We noticed an increase in serum IDO activity in our COPD cohort (Figure 4), which might be stimulated by IFN-γ or other pro-inflammatory cytokines (70) that are released in consequence of ongoing lung inflammation (71). This evidence concerns the gene IFNG and chronic obstructive pulmonary disease.